Works matching DE "PHARMACEUTICAL reference pricing"
Results: 37
Pricing matrix model: dealing with uncertainty.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
- Published in:
- Pharmacy World & Science, 2008, v. 30, n. 1, p. 57
- By:
- Publication type:
- Article
The EpiPen Problem: Analyzing Unethical Drug Price Increases and the Need for Greater Government Regulation.
- Published in:
- University of Miami Business Law Review, 2017, v. 26, n. 1, p. 129
- By:
- Publication type:
- Article
Top 10 drugs.
- Published in:
- Australian Prescriber, 2010, v. 33, n. 6, p. 181, doi. 10.18773/austprescr.2010.085
- Publication type:
- Article
Your questions to the PBAC.
- Published in:
- Australian Prescriber, 2010, v. 33, n. 5, p. 144
- By:
- Publication type:
- Article
Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.
- Published in:
- Croatian Medical Journal, 2011, v. 52, n. 2, p. 183, doi. 10.3325/cmj.2011.52.183
- By:
- Publication type:
- Article
No matter who wins, pharmacy will lose.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
The growth imperative: preparing for a changing tide in pharmacy profitability.
- Published in:
- Australian Journal of Pharmacy, 2010, v. 91, n. 1086, p. 8
- By:
- Publication type:
- Article
Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Low-Cost Pharma.
- Published in:
- National Medical Journal of India, 2018, v. 31, n. 3, p. 176, doi. 10.4103/0970-258x.255764
- By:
- Publication type:
- Article
The international drug price indicator guide: An objective source of information about medicine prices.
- Published in:
- Indian Journal of Pharmacology, 2014, v. 46, n. 6, p. 662, doi. 10.4103/0253-7613.144949
- By:
- Publication type:
- Article
Crimes against humanity.
- Published in:
- Rhode Island Medical Journal, 2017, v. 100, n. 6, p. 8
- By:
- Publication type:
- Article
Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
- Published in:
- Health Policy & Planning, 2010, v. 25, n. 3, p. 219, doi. 10.1093/heapol/czp056
- By:
- Publication type:
- Article
How Reference Pricing for Pharmaceuticals Can Increase Generic Share of Market: The Slovenian Experience.
- Published in:
- Journal of Public Policy & Marketing, 2007, v. 26, n. 1, p. 89, doi. 10.1509/jppm.26.1.89
- By:
- Publication type:
- Article
Recent Developments in Health Law.
- Published in:
- Journal of Law, Medicine & Ethics, 2011, v. 39, n. 2, p. 291, doi. 10.1111/j.1748-720X.2011.00599.x
- By:
- Publication type:
- Article
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rebates-The Little-Known Factor Behind Increasing Drug List Prices.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High costs for seniors.
- Published in:
- Fraser Forum, 2009, p. 24
- By:
- Publication type:
- Article
The wrong answer to high drug prices.
- Published in:
- Fraser Forum, 2009, p. 7
- By:
- Publication type:
- Article
The dilemma of high drug prices.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Pharmacy Benefit Managers, Rebates, and Drug Prices: Conflicts of Interest in the Market for Prescription Drugs.
- Published in:
- Yale Law & Policy Review, 2020, v. 38, n. 2, p. 360
- By:
- Publication type:
- Article
Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia.
- Published in:
- PLoS Medicine, 2007, v. 4, n. 3, p. 0466, doi. 10.1371/journal.pmed.0040082
- By:
- Publication type:
- Article
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 2, p. 251, doi. 10.1007/s41669-023-00467-2
- By:
- Publication type:
- Article
Evaluación positiva de medicamentos: septiembre, octubre y noviembre de 2023.
- Published in:
- Sanidad Militar, 2023, v. 79, n. 4, p. 272, doi. 10.4321/S1887-85712023000400010
- By:
- Publication type:
- Article
Proposed methodology for monitoring antiretroviral drugs price negotiations in Latin America and the Caribbean.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2009, v. 26, n. 2, p. 137, doi. 10.1590/S1020-49892009000800006
- By:
- Publication type:
- Article
Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice.
- Published in:
- Journal of Evaluation in Clinical Practice, 2008, v. 14, n. 6, p. 969, doi. 10.1111/j.1365-2753.2007.00913.x
- By:
- Publication type:
- Article
"For the strength of the pack is the wolf, and the strength of wolf is the pack".
- Published in:
- SA Pharmaceutical Journal Incorporating Pharmacy Management, 2017, v. 84, n. 4, p. 6
- By:
- Publication type:
- Article
Grenzen der Zulässigkeit und der Ausgestaltung von Preismodellen für Arzneimittel im Erstattungskodex.
- Published in:
- Journal für Medizin- und Gesundheitsrecht (JMG), 2020, n. 3, p. 143, doi. 10.37942/jmg202003014301
- By:
- Publication type:
- Article
Value-Based Pricing: L'Enfant Terrible?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 4, p. 367, doi. 10.1007/s40273-014-0241-z
- By:
- Publication type:
- Article
Indication-Specific Pricing for Cancer Drugs.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Innovation-Innovation Tradeoffs in Drug Pricing.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A drug cost model for injuries due to road traffic accidents.
- Published in:
- Pharmacy Practice (1886-3655), 2008, v. 6, n. 1, p. 9, doi. 10.4321/S1886-36552008000100002
- By:
- Publication type:
- Article
Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other.
- Published in:
- Tropical Medicine & International Health, 2008, v. 13, n. 9, p. 1204, doi. 10.1111/j.1365-3156.2008.02127.x
- By:
- Publication type:
- Article
PPMA urges PM to sign Drug Prices Summary sent by DRAP.
- Published in:
- Pulse International, 2017, v. 18, n. 15, p. 8
- Publication type:
- Article
The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change.
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1369817
- By:
- Publication type:
- Article